BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diederich NJ, James Surmeier D, Uchihara T, Grillner S, Goetz CG. Parkinson's disease: Is it a consequence of human brain evolution? Mov Disord 2019;34:453-9. [PMID: 30759321 DOI: 10.1002/mds.27628] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Chiou KL, Decasien AR, Rees KP, Testard C, Spurrell CH, Gogate AA, Pliner HA, Tremblay S, Mercer A, Whalen CJ, Negrón-del Valle JE, Janiak MC, Bauman Surratt SE, González O, Compo NR, Stock MK, Ruiz-lambides AV, Martínez MI, Wilson MA, Melin AD, Antón SC, Walker CS, Sallet J, Newbern JM, Starita LM, Shendure J, Higham JP, Brent LJN, Montague MJ, Platt ML, Snyder-mackler N, Cayo Biobank Research Unit. Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environment. Nat Neurosci 2022. [DOI: 10.1038/s41593-022-01197-0] [Reference Citation Analysis]
2 Bagarinao E, Kawabata K, Watanabe H, Hara K, Ohdake R, Ogura A, Masuda M, Kato T, Maesawa S, Katsuno M, Sobue G. Connectivity impairment of cerebellar and sensorimotor connector hubs in Parkinson’s disease. Brain Communications 2022;4. [DOI: 10.1093/braincomms/fcac214] [Reference Citation Analysis]
3 Alarcon-Gil J, Sierra-Magro A, Morales-Garcia JA, Sanz-SanCristobal M, Alonso-Gil S, Cortes-Canteli M, Niso-Santano M, Martínez-Chacón G, Fuentes JM, Santos A, Perez-Castillo A. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson's Disease: The Implication of Lipid Droplets and Lipophagy. Cells 2022;11:2297. [PMID: 35892594 DOI: 10.3390/cells11152297] [Reference Citation Analysis]
4 Chen Z, Reynolds RH, Pardiñas AF, Gagliano Taliun SA, van Rheenen W, Lin K, Shatunov A, Gustavsson EK, Fogh I, Jones AR, Robberecht W, Corcia P, Chiò A, Shaw PJ, Morrison KE, Veldink JH, van den Berg LH, Shaw CE, Powell JF, Silani V, Hardy JA, Houlden H, Owen MJ, Turner MR, Ryten M, Al-chalabi A. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.. [DOI: 10.1101/2022.04.29.490053] [Reference Citation Analysis]
5 Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K. Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase. IJMS 2022;23:4176. [DOI: 10.3390/ijms23084176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ardanaz CG, Ramírez MJ, Solas M. Brain Metabolic Alterations in Alzheimer's Disease. Int J Mol Sci 2022;23:3785. [PMID: 35409145 DOI: 10.3390/ijms23073785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Henderson MX, Henrich MT, Geibl FF, Oertel WH, Brundin P, Surmeier DJ. The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Schmitz MT, Sandoval K, Chen CP, Mostajo-Radji MA, Seeley WW, Nowakowski TJ, Ye CJ, Paredes MF, Pollen AA. The development and evolution of inhibitory neurons in primate cerebrum. Nature 2022;603:871-7. [PMID: 35322231 DOI: 10.1038/s41586-022-04510-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
9 Liss B, Surmeier DJ. Calcium Channels and Selective Neuronal Vulnerability in Parkinson’s Disease. Voltage-Gated Calcium Channels 2022. [DOI: 10.1007/978-3-031-08881-0_22] [Reference Citation Analysis]
10 Watanabe H, Bagarinao E, Maesawa S, Hara K, Kawabata K, Ogura A, Ohdake R, Shima S, Mizutani Y, Ueda A, Ito M, Katsuno M, Sobue G. Characteristics of Neural Network Changes in Normal Aging and Early Dementia. Front Aging Neurosci 2021;13:747359. [PMID: 34880745 DOI: 10.3389/fnagi.2021.747359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Barbuti PA, Ohnmacht J, Santos BFR, Antony PM, Massart F, Cruciani G, Dording CM, Pavelka L, Casadei N, Kwon YJ, Krüger R. Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function. Sci Rep 2021;11:21946. [PMID: 34754035 DOI: 10.1038/s41598-021-01505-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 González-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L, Kaplitt MG, López-Barneo J, Schumacker PT, Surmeier DJ. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 2021;599:650-6. [PMID: 34732887 DOI: 10.1038/s41586-021-04059-0] [Cited by in Crossref: 80] [Cited by in F6Publishing: 91] [Article Influence: 80.0] [Reference Citation Analysis]
13 Yao Y, Dai J. Naturally Occurring Parkinson's Disease Raises the Need for Nonhuman Primates in Neurodegenerative Diseases Research. Neurosci Bull 2021;37:1267-9. [PMID: 34037946 DOI: 10.1007/s12264-021-00708-6] [Reference Citation Analysis]
14 Chen Z, Zhang D, Reynolds RH, Gustavsson EK, García-Ruiz S, D'Sa K, Fairbrother-Browne A, Vandrovcova J, Hardy J, Houlden H, Gagliano Taliun SA, Botía J, Ryten M; International Parkinson’s Disease Genomics Consortium (IPDGC). Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage. Nat Commun 2021;12:2076. [PMID: 33824317 DOI: 10.1038/s41467-021-22262-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gundersen V. Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy? Front Neurosci 2020;14:580311. [PMID: 33716638 DOI: 10.3389/fnins.2020.580311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Gonçalves VC, Cuenca-Bermejo L, Fernandez-Villalba E, Martin-Balbuena S, da Silva Fernandes MJ, Scorza CA, Herrero MT. Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson's Disease. Neuroscientist 2021;:1073858421990000. [PMID: 33583239 DOI: 10.1177/1073858421990000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Betrouni N, Moreau C, Rolland AS, Carrière N, Chupin M, Kuchcinski G, Lopes R, Viard R, Defebvre L, Devos D. Texture-based markers from structural imaging correlate with motor handicap in Parkinson's disease. Sci Rep 2021;11:2724. [PMID: 33526820 DOI: 10.1038/s41598-021-81209-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Barbuti PA, Santos BF, Antony PM, Massart F, Cruciani G, Dording CM, Pavelka L, Kwon Y, Krüger R. Gene-corrected Parkinson’s disease neurons show the A30P alpha-synuclein point mutation leads to reduced neuronal branching and function.. [DOI: 10.1101/2020.11.05.369389] [Reference Citation Analysis]
19 Grillner S, Robertson B, Kotaleski JH. Basal Ganglia—A Motion Perspective. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1241-75. [DOI: 10.1002/cphy.c190045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Zampese E, Surmeier DJ. Calcium, Bioenergetics, and Parkinson's Disease. Cells 2020;9:E2045. [PMID: 32911641 DOI: 10.3390/cells9092045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
21 Diederich NJ, Uchihara T, Grillner S, Goetz CG. The Evolution-Driven Signature of Parkinson's Disease. Trends Neurosci 2020;43:475-92. [PMID: 32499047 DOI: 10.1016/j.tins.2020.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
22 Chen Z, Zhang D, Reynolds RH, Gustavsson EK, Ruiz SG, D’sa K, Fairbrother-browne A, Vandrovcova J, Hardy J, Houlden H, Taliun SAG, Botía J, Ryten M, International Parkinson’s Disease Genomics Consortium (IPDGC). Human-lineage-specific genomic elements: relevance to neurodegenerative disease and APOE transcript usage.. [DOI: 10.1101/2020.04.17.046441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Gonzalez-Rodriguez P, Zampese E, Surmeier DJ. Selective neuronal vulnerability in Parkinson's disease. Prog Brain Res 2020;252:61-89. [PMID: 32247375 DOI: 10.1016/bs.pbr.2020.02.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
24 Cenci MA, Björklund A. Animal models for preclinical Parkinson's research: An update and critical appraisal. Prog Brain Res 2020;252:27-59. [PMID: 32247366 DOI: 10.1016/bs.pbr.2020.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 7.5] [Reference Citation Analysis]
25 Dando MR. Japan’s Brain/MINDS Project. Neuroscience and the Problem of Dual Use 2020. [DOI: 10.1007/978-3-030-53790-6_8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tönges L, Zella MAS. Antibody-based immunotherapies for Parkinsonian syndromes. Neural Regen Res 2019;14:1903-4. [PMID: 31290443 DOI: 10.4103/1673-5374.259613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Vila M. Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease. Mov Disord 2019;34:1440-51. [PMID: 31251435 DOI: 10.1002/mds.27776] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
28 Obeso JA. Editor's note: The origin of Parkinson's disease: The importance of environment and lifestyle. Mov Disord 2019;34:799-800. [PMID: 31206833 DOI: 10.1002/mds.27743] [Reference Citation Analysis]